{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:34:34Z","timestamp":1776818074526,"version":"3.51.2"},"publisher-location":"Singapore","reference-count":184,"publisher":"Springer Singapore","isbn-type":[{"value":"9789811382727","type":"print"},{"value":"9789811382734","type":"electronic"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/978-981-13-8273-4_23","type":"book-chapter","created":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T15:04:12Z","timestamp":1573052652000},"page":"509-537","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Role of Oxidative Stress in the Pathophysiology of Arterial Hypertension and Heart Failure"],"prefix":"10.1007","author":[{"given":"Teresa","family":"Sousa","sequence":"first","affiliation":[]},{"given":"Marta","family":"Reina-Couto","sequence":"additional","affiliation":[]},{"given":"Pedro","family":"Gomes","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2019,11,7]]},"reference":[{"issue":"8","key":"23_CR1","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/nchembio.607","volume":"7","author":"BC Dickinson","year":"2011","unstructured":"Dickinson BC, Chang CJ (2011) Chemistry and biology of reactive oxygen species in signaling or stress responses. Nat Chem Biol 7(8):504\u2013511","journal-title":"Nat Chem Biol"},{"issue":"1","key":"23_CR2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1152\/physrev.00018.2001","volume":"82","author":"W Droge","year":"2002","unstructured":"Droge W (2002) Free radicals in the physiological control of cell function. Physiol Rev 82(1):47\u201395","journal-title":"Physiol Rev"},{"issue":"10","key":"23_CR3","doi-asserted-by":"publisher","first-page":"R453","DOI":"10.1016\/j.cub.2014.03.034","volume":"24","author":"M Schieber","year":"2014","unstructured":"Schieber M, Chandel NS (2014) ROS function in redox signaling and oxidative stress. Curr Biol 24(10):R453\u2013R462","journal-title":"Curr Biol"},{"key":"23_CR4","doi-asserted-by":"publisher","first-page":"936486","DOI":"10.1155\/2012\/936486","volume":"2012","author":"AA Alfadda","year":"2012","unstructured":"Alfadda AA, Sallam RM (2012) Reactive oxygen species in health and disease. J Biomed Biotechnol 2012:936486","journal-title":"J Biomed Biotechnol"},{"issue":"1","key":"23_CR5","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.biocel.2006.07.001","volume":"39","author":"M Valko","year":"2007","unstructured":"Valko M et al (2007) Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39(1):44\u201384","journal-title":"Int J Biochem Cell Biol"},{"issue":"9","key":"23_CR6","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1089\/ars.2012.4914","volume":"18","author":"AC Brewer","year":"2013","unstructured":"Brewer AC et al (2013) Reductive stress linked to small HSPs, G6PD, and Nrf2 pathways in heart disease. Antioxid Redox Signal 18(9):1114\u20131127","journal-title":"Antioxid Redox Signal"},{"issue":"3","key":"23_CR7","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1089\/ars.2007.1993","volume":"11","author":"MC Martinez","year":"2009","unstructured":"Martinez MC, Andriantsitohaina R (2009) Reactive nitrogen species: molecular mechanisms and potential significance in health and disease. Antioxid Redox Signal 11(3):669\u2013702","journal-title":"Antioxid Redox Signal"},{"issue":"4","key":"23_CR8","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1124\/pr.54.4.619","volume":"54","author":"IV Turko","year":"2002","unstructured":"Turko IV, Murad F (2002) Protein nitration in cardiovascular diseases. Pharmacol Rev 54(4):619\u2013634","journal-title":"Pharmacol Rev"},{"issue":"1","key":"23_CR9","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.repc.2015.09.006","volume":"35","author":"S Costa","year":"2016","unstructured":"Costa S et al (2016) Statins and oxidative stress in chronic heart failure. Rev Port Cardiol 35(1):41\u201357","journal-title":"Rev Port Cardiol"},{"key":"23_CR10","first-page":"345","volume-title":"Lipid peroxidation","author":"T Sousa","year":"2012","unstructured":"Sousa T et al (2012) Lipid peroxidation and antioxidants in arterial hypertension. In: Catala A (ed) Lipid peroxidation. IntechOpen, Rijeka, pp 345\u2013392"},{"issue":"3","key":"23_CR11","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1161\/CIRCRESAHA.114.300559","volume":"114","author":"YR Chen","year":"2014","unstructured":"Chen YR, Zweier JL (2014) Cardiac mitochondria and reactive oxygen species generation. Circ Res 114(3):524\u2013537","journal-title":"Circ Res"},{"issue":"1","key":"23_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BJ20081386","volume":"417","author":"MP Murphy","year":"2009","unstructured":"Murphy MP (2009) How mitochondria produce reactive oxygen species. Biochem J 417(1):1\u201313","journal-title":"Biochem J"},{"issue":"6","key":"23_CR13","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1161\/HYPERTENSIONAHA.109.130054","volume":"53","author":"F Addabbo","year":"2009","unstructured":"Addabbo F, Montagnani M, Goligorsky MS (2009) Mitochondria and reactive oxygen species. Hypertension 53(6):885\u2013892","journal-title":"Hypertension"},{"issue":"3","key":"23_CR14","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1152\/physrev.1979.59.3.527","volume":"59","author":"B Chance","year":"1979","unstructured":"Chance B, Sies H, Boveris A (1979) Hydroperoxide metabolism in mammalian organs. Physiol Rev 59(3):527\u2013605","journal-title":"Physiol Rev"},{"issue":"8","key":"23_CR15","doi-asserted-by":"publisher","first-page":"H1131","DOI":"10.1152\/ajpheart.00063.2013","volume":"305","author":"RR Nazarewicz","year":"2013","unstructured":"Nazarewicz RR et al (2013) Nox2 as a potential target of mitochondrial superoxide and its role in endothelial oxidative stress. Am J Physiol Heart Circ Physiol 305(8):H1131\u2013H1140","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"23_CR16","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/ki.2011.29","volume":"80","author":"A Zhang","year":"2011","unstructured":"Zhang A et al (2011) Relative contributions of mitochondria and NADPH oxidase to deoxycorticosterone acetate-salt hypertension in mice. Kidney Int 80(1):51\u201360","journal-title":"Kidney Int"},{"issue":"3","key":"23_CR17","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1161\/CIRCRESAHA.118.312708","volume":"123","author":"S Dey","year":"2018","unstructured":"Dey S et al (2018) Mitochondrial ROS drive sudden cardiac death and chronic proteome remodeling in heart failure. Circ Res 123(3):356\u2013371","journal-title":"Circ Res"},{"issue":"16","key":"23_CR18","doi-asserted-by":"publisher","first-page":"324","DOI":"10.21037\/atm.2017.06.17","volume":"5","author":"D Moris","year":"2017","unstructured":"Moris D et al (2017) The role of reactive oxygen species in myocardial redox signaling and regulation. Ann Transl Med 5(16):324","journal-title":"Ann Transl Med"},{"issue":"6","key":"23_CR19","doi-asserted-by":"publisher","first-page":"H2181","DOI":"10.1152\/ajpheart.00554.2011","volume":"301","author":"H Tsutsui","year":"2011","unstructured":"Tsutsui H, Kinugawa S, Matsushima S (2011) Oxidative stress and heart failure. Am J Physiol Heart Circ Physiol 301(6):H2181\u2013H2190","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"23_CR20","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1152\/physrev.00044.2005","volume":"87","author":"K Bedard","year":"2007","unstructured":"Bedard K, Krause KH (2007) The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 87(1):245\u2013313","journal-title":"Physiol Rev"},{"issue":"3","key":"23_CR21","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1161\/HYPERTENSIONAHA.109.142422","volume":"56","author":"SR Datla","year":"2010","unstructured":"Datla SR, Griendling KK (2010) Reactive oxygen species, NADPH oxidases, and hypertension. Hypertension 56(3):325\u2013330","journal-title":"Hypertension"},{"issue":"12","key":"23_CR22","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1089\/ars.2008.2034","volume":"10","author":"R Nistala","year":"2008","unstructured":"Nistala R, Whaley-Connell A, Sowers JR (2008) Redox control of renal function and hypertension. Antioxid Redox Signal 10(12):2047\u20132089","journal-title":"Antioxid Redox Signal"},{"issue":"6","key":"23_CR23","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1161\/ATVBAHA.111.226894","volume":"31","author":"RP Brandes","year":"2011","unstructured":"Brandes RP, Takac I, Schroder K (2011) No superoxide--no stress?: Nox4, the good NADPH oxidase! Arterioscler Thromb Vasc Biol 31(6):1255\u20131257","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"9","key":"23_CR24","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/j.freeradbiomed.2009.07.023","volume":"47","author":"DI Brown","year":"2009","unstructured":"Brown DI, Griendling KK (2009) Nox proteins in signal transduction. Free Radic Biol Med 47(9):1239\u20131253","journal-title":"Free Radic Biol Med"},{"issue":"10","key":"23_CR25","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1681\/ASN.2012111112","volume":"24","author":"M Sedeek","year":"2013","unstructured":"Sedeek M et al (2013) NADPH oxidases, reactive oxygen species, and the kidney: friend and foe. J Am Soc Nephrol 24(10):1512\u20131518","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"23_CR26","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1097\/MNH.0000000000000153","volume":"24","author":"AC Montezano","year":"2015","unstructured":"Montezano AC et al (2015) Redox signaling, Nox5 and vascular remodeling in hypertension. Curr Opin Nephrol Hypertens 24(5):425\u2013433","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"23_CR27","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.redox.2014.01.020","volume":"2","author":"P Yu","year":"2014","unstructured":"Yu P et al (2014) Unique role of NADPH oxidase 5 in oxidative stress in human renal proximal tubule cells. Redox Biol 2:570\u2013579","journal-title":"Redox Biol"},{"issue":"1","key":"23_CR28","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.bbrc.2015.04.021","volume":"461","author":"A Manea","year":"2015","unstructured":"Manea A et al (2015) Human monocytes and macrophages express NADPH oxidase 5; a potential source of reactive oxygen species in atherosclerosis. Biochem Biophys Res Commun 461(1):172\u2013179","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"23_CR29","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.jacc.2017.05.035","volume":"70","author":"T Munzel","year":"2017","unstructured":"Munzel T et al (2017) Impact of oxidative stress on the heart and vasculature: part 2 of a 3-part series. J Am Coll Cardiol 70(2):212\u2013229","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"23_CR30","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1089\/ars.2012.4550","volume":"18","author":"M Zhang","year":"2013","unstructured":"Zhang M et al (2013) NADPH oxidases in heart failure: poachers or gamekeepers? Antioxid Redox Signal 18(9):1024\u20131041","journal-title":"Antioxid Redox Signal"},{"issue":"8","key":"23_CR31","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1161\/CIRCRESAHA.111.300171","volume":"112","author":"S Matsushima","year":"2013","unstructured":"Matsushima S et al (2013) Broad suppression of NADPH oxidase activity exacerbates ischemia\/reperfusion injury through inadvertent downregulation of hypoxia-inducible factor-1alpha and upregulation of peroxisome proliferator-activated receptor-alpha. Circ Res 112(8):1135\u20131149","journal-title":"Circ Res"},{"issue":"1","key":"23_CR32","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3164\/jcbn.11-006FR","volume":"48","author":"MJ Davies","year":"2011","unstructured":"Davies MJ (2011) Myeloperoxidase-derived oxidation: mechanisms of biological damage and its prevention. J Clin Biochem Nutr 48(1):8\u201319","journal-title":"J Clin Biochem Nutr"},{"issue":"5","key":"23_CR33","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3109\/08037051.2012.759331","volume":"22","author":"YC Liu","year":"2013","unstructured":"Liu YC et al (2013) Genetic polymorphisms of myeloperoxidase and their effect on hypertension. Blood Press 22(5):282\u2013289","journal-title":"Blood Press"},{"issue":"2","key":"23_CR34","doi-asserted-by":"publisher","first-page":"115","DOI":"10.2174\/1568026611313020004","volume":"13","author":"N Anatoliotakis","year":"2013","unstructured":"Anatoliotakis N et al (2013) Myeloperoxidase: expressing inflammation and oxidative stress in cardiovascular disease. Curr Top Med Chem 13(2):115\u2013138","journal-title":"Curr Top Med Chem"},{"issue":"15","key":"23_CR35","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1161\/CIRCULATIONAHA.105.590083","volume":"113","author":"S Baldus","year":"2006","unstructured":"Baldus S et al (2006) Heparins increase endothelial nitric oxide bioavailability by liberating vessel-immobilized myeloperoxidase. Circulation 113(15):1871\u20131878","journal-title":"Circulation"},{"issue":"6","key":"23_CR36","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1089\/ars.2012.4783","volume":"18","author":"C Nussbaum","year":"2013","unstructured":"Nussbaum C et al (2013) Myeloperoxidase: a leukocyte-derived protagonist of inflammation and cardiovascular disease. Antioxid Redox Signal 18(6):692\u2013713","journal-title":"Antioxid Redox Signal"},{"issue":"24","key":"23_CR37","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1016\/j.jacc.2007.02.053","volume":"49","author":"WH Tang","year":"2007","unstructured":"Tang WH et al (2007) Prognostic value and echocardiographic determinants of plasma myeloperoxidase levels in chronic heart failure. J Am Coll Cardiol 49(24):2364\u20132370","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"23_CR38","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1093\/eurheartj\/ehr304","volume":"33","author":"U Forstermann","year":"2012","unstructured":"Forstermann U, Sessa WC (2012) Nitric oxide synthases: regulation and function. Eur Heart J 33(7):829\u2013837","journal-title":"Eur Heart J"},{"issue":"2","key":"23_CR39","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/S0008-6363(02)00327-9","volume":"55","author":"MT Gewaltig","year":"2002","unstructured":"Gewaltig MT, Kojda G (2002) Vasoprotection by nitric oxide: mechanisms and therapeutic potential. Cardiovasc Res 55(2):250\u2013260","journal-title":"Cardiovasc Res"},{"issue":"4","key":"23_CR40","doi-asserted-by":"publisher","first-page":"295","DOI":"10.5527\/wjn.v3.i4.295","volume":"3","author":"S Horita","year":"2014","unstructured":"Horita S et al (2014) Regulatory roles of nitric oxide and angiotensin II on renal tubular transport. World J Nephrol 3(4):295\u2013301","journal-title":"World J Nephrol"},{"issue":"5","key":"23_CR41","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1161\/01.RES.0000088351.58510.21","volume":"93","author":"PB Massion","year":"2003","unstructured":"Massion PB et al (2003) Nitric oxide and cardiac function: ten years after, and continuing. Circ Res 93(5):388\u2013398","journal-title":"Circ Res"},{"issue":"2","key":"23_CR42","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s11906-010-0100-z","volume":"12","author":"AM Briones","year":"2010","unstructured":"Briones AM, Touyz RM (2010) Oxidative stress and hypertension: current concepts. Curr Hypertens Rep 12(2):135\u2013142","journal-title":"Curr Hypertens Rep"},{"issue":"12","key":"23_CR43","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1016\/j.jacc.2006.01.071","volume":"47","author":"H Li","year":"2006","unstructured":"Li H et al (2006) Reversal of endothelial nitric oxide synthase uncoupling and up-regulation of endothelial nitric oxide synthase expression lowers blood pressure in hypertensive rats. J Am Coll Cardiol 47(12):2536\u20132544","journal-title":"J Am Coll Cardiol"},{"key":"23_CR44","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.ijcard.2015.04.162","volume":"190","author":"E Yamamoto","year":"2015","unstructured":"Yamamoto E et al (2015) The pivotal role of eNOS uncoupling in vascular endothelial dysfunction in patients with heart failure with preserved ejection fraction. Int J Cardiol 190:335\u2013337","journal-title":"Int J Cardiol"},{"issue":"20","key":"23_CR45","doi-asserted-by":"publisher","first-page":"2626","DOI":"10.1161\/CIRCULATIONAHA.107.737031","volume":"117","author":"AL Moens","year":"2008","unstructured":"Moens AL et al (2008) Reversal of cardiac hypertrophy and fibrosis from pressure overload by tetrahydrobiopterin: efficacy of recoupling nitric oxide synthase as a therapeutic strategy. Circulation 117(20):2626\u20132636","journal-title":"Circulation"},{"issue":"Pt 3","key":"23_CR46","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1113\/jphysiol.2003.055913","volume":"555","author":"CE Berry","year":"2004","unstructured":"Berry CE, Hare JM (2004) Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications. J Physiol 555(Pt 3):589\u2013606","journal-title":"J Physiol"},{"issue":"3","key":"23_CR47","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.bcp.2005.05.009","volume":"70","author":"N Kuzkaya","year":"2005","unstructured":"Kuzkaya N et al (2005) Interactions of peroxynitrite with uric acid in the presence of ascorbate and thiols: implications for uncoupling endothelial nitric oxide synthase. Biochem Pharmacol 70(3):343\u2013354","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"23_CR48","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1073\/pnas.95.2.675","volume":"95","author":"DC Hooper","year":"1998","unstructured":"Hooper DC et al (1998) Uric acid, a natural scavenger of peroxynitrite, in experimental allergic encephalomyelitis and multiple sclerosis. Proc Natl Acad Sci U S A 95(2):675\u2013680","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"23_CR49","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1161\/01.HYP.0000069700.62727.C5","volume":"41","author":"RJ Johnson","year":"2003","unstructured":"Johnson RJ et al (2003) Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 41(6):1183\u20131190","journal-title":"Hypertension"},{"issue":"14","key":"23_CR50","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1001\/archinte.164.14.1546","volume":"164","author":"LK Niskanen","year":"2004","unstructured":"Niskanen LK et al (2004) Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study. Arch Intern Med 164(14):1546\u20131551","journal-title":"Arch Intern Med"},{"issue":"1","key":"23_CR51","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.mcna.2016.08.004","volume":"101","author":"R Loperena","year":"2017","unstructured":"Loperena R, Harrison DG (2017) Oxidative stress and hypertensive diseases. Med Clin North Am 101(1):169\u2013193","journal-title":"Med Clin North Am"},{"issue":"8","key":"23_CR52","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1001\/jama.300.8.924","volume":"300","author":"DI Feig","year":"2008","unstructured":"Feig DI, Soletsky B, Johnson RJ (2008) Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial. JAMA 300(8):924\u2013932","journal-title":"JAMA"},{"issue":"3","key":"23_CR53","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1161\/HYPERTENSIONAHA.115.06344","volume":"67","author":"RL MacIsaac","year":"2016","unstructured":"MacIsaac RL et al (2016) Allopurinol and cardiovascular outcomes in adults with hypertension. Hypertension 67(3):535\u2013540","journal-title":"Hypertension"},{"issue":"2","key":"23_CR54","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1161\/01.ATV.0000196651.64776.51","volume":"26","author":"TJ Guzik","year":"2006","unstructured":"Guzik TJ et al (2006) Coronary artery superoxide production and NOX isoform expression in human coronary artery disease. Arterioscler Thromb Vasc Biol 26(2):333\u2013339","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"8","key":"23_CR55","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/j.freeradbiomed.2006.07.010","volume":"41","author":"S Baldus","year":"2006","unstructured":"Baldus S et al (2006) Inhibition of xanthine oxidase improves myocardial contractility in patients with ischemic cardiomyopathy. Free Radic Biol Med 41(8):1282\u20131288","journal-title":"Free Radic Biol Med"},{"issue":"20","key":"23_CR56","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1161\/CIRCULATIONAHA.114.014536","volume":"131","author":"MM Givertz","year":"2015","unstructured":"Givertz MM et al (2015) Effects of xanthine oxidase inhibition in hyperuricemic heart failure patients: the xanthine oxidase inhibition for hyperuricemic heart failure patients (EXACT-HF) study. Circulation 131(20):1763\u20131771","journal-title":"Circulation"},{"issue":"24","key":"23_CR57","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1016\/j.jacc.2008.01.068","volume":"51","author":"JM Hare","year":"2008","unstructured":"Hare JM et al (2008) Impact of oxypurinol in patients with symptomatic heart failure. Results of the OPT-CHF study. J Am Coll Cardiol 51(24):2301\u20132309","journal-title":"J Am Coll Cardiol"},{"issue":"14","key":"23_CR58","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1089\/ars.2015.6433","volume":"23","author":"AI Casas","year":"2015","unstructured":"Casas AI et al (2015) Reactive oxygen-related diseases: therapeutic targets and emerging clinical indications. Antioxid Redox Signal 23(14):1171\u20131185","journal-title":"Antioxid Redox Signal"},{"key":"23_CR59","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.coph.2017.04.003","volume":"33","author":"S Deshwal","year":"2017","unstructured":"Deshwal S et al (2017) Emerging role of monoamine oxidase as a therapeutic target for cardiovascular disease. Curr Opin Pharmacol 33:64\u201369","journal-title":"Curr Opin Pharmacol"},{"issue":"7","key":"23_CR60","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/j.bbamcr.2010.09.010","volume":"1813","author":"N Kaludercic","year":"2011","unstructured":"Kaludercic N et al (2011) Monoamine oxidases (MAO) in the pathogenesis of heart failure and ischemia\/reperfusion injury. Biochim Biophys Acta 1813(7):1323\u20131332","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"23_CR61","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1089\/ars.2011.3999","volume":"15","author":"T Fukai","year":"2011","unstructured":"Fukai T, Ushio-Fukai M (2011) Superoxide dismutases: role in redox signaling, vascular function, and diseases. Antioxid Redox Signal 15(6):1583\u20131606","journal-title":"Antioxid Redox Signal"},{"issue":"7","key":"23_CR62","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1089\/ars.2010.3586","volume":"15","author":"E Lubos","year":"2011","unstructured":"Lubos E, Loscalzo J, Handy DE (2011) Glutathione peroxidase-1 in health and disease: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal 15(7):1957\u20131997","journal-title":"Antioxid Redox Signal"},{"issue":"4","key":"23_CR63","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1161\/01.HYP.0000142232.29764.a7","volume":"44","author":"S Wassmann","year":"2004","unstructured":"Wassmann S, Wassmann K, Nickenig G (2004) Modulation of oxidant and antioxidant enzyme expression and function in vascular cells. Hypertension 44(4):381\u2013386","journal-title":"Hypertension"},{"issue":"1","key":"23_CR64","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/cr.2010.178","volume":"21","author":"MJ Morgan","year":"2011","unstructured":"Morgan MJ, Liu ZG (2011) Crosstalk of reactive oxygen species and NF-kappaB signaling. Cell Res 21(1):103\u2013115","journal-title":"Cell Res"},{"issue":"33","key":"23_CR65","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","volume":"39","author":"B Williams","year":"2018","unstructured":"Williams B et al (2018) ESC\/ESH guidelines for the management of arterial hypertension. Eur Heart J 39(33):3021\u20133104","journal-title":"Eur Heart J"},{"issue":"11","key":"23_CR66","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1038\/nm.2541","volume":"17","author":"TM Coffman","year":"2011","unstructured":"Coffman TM (2011) Under pressure: the search for the essential mechanisms of hypertension. Nat Med 17(11):1402\u20131409","journal-title":"Nat Med"},{"issue":"2","key":"23_CR67","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1161\/HYPERTENSIONAHA.109.144477","volume":"55","author":"RL Davisson","year":"2010","unstructured":"Davisson RL, Zimmerman MC (2010) Angiotensin II, oxidant signaling, and hypertension: down to a T? Hypertension 55(2):228\u2013230","journal-title":"Hypertension"},{"issue":"3","key":"23_CR68","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1124\/pr.59.3.3","volume":"59","author":"H Kobori","year":"2007","unstructured":"Kobori H et al (2007) The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev 59(3):251\u2013287","journal-title":"Pharmacol Rev"},{"issue":"4","key":"23_CR69","first-page":"R893","volume":"284","author":"JF Reckelhoff","year":"2003","unstructured":"Reckelhoff JF, Romero JC (2003) Role of oxidative stress in angiotensin-induced hypertension. Am J Phys Regul Integr Comp Phys 284(4):R893\u2013R912","journal-title":"Am J Phys Regul Integr Comp Phys"},{"issue":"12 Pt 3","key":"23_CR70","doi-asserted-by":"publisher","first-page":"205S","DOI":"10.1016\/S0895-7061(99)00103-X","volume":"12","author":"MR Weir","year":"1999","unstructured":"Weir MR, Dzau VJ (1999) The renin-angiotensin-aldosterone system: a specific target for hypertension management. Am J Hypertens 12(12 Pt 3):205S\u2013213S","journal-title":"Am J Hypertens"},{"issue":"2","key":"23_CR71","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1161\/01.RES.0000135483.12297.e4","volume":"95","author":"MC Zimmerman","year":"2004","unstructured":"Zimmerman MC et al (2004) Hypertension caused by angiotensin II infusion involves increased superoxide production in the central nervous system. Circ Res 95(2):210\u2013216","journal-title":"Circ Res"},{"issue":"1","key":"23_CR72","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1161\/01.HYP.0000074903.96928.91","volume":"42","author":"A Makino","year":"2003","unstructured":"Makino A et al (2003) Increased renal medullary H2O2 leads to hypertension. Hypertension 42(1):25\u201330","journal-title":"Hypertension"},{"issue":"8","key":"23_CR73","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1111\/j.1476-5381.2012.01957.x","volume":"166","author":"T Sousa","year":"2012","unstructured":"Sousa T et al (2012) Role of H(2)O(2) in hypertension, renin-angiotensin system activation and renal medullary disfunction caused by angiotensin II. Br J Pharmacol 166(8):2386\u20132401","journal-title":"Br J Pharmacol"},{"issue":"3","key":"23_CR74","doi-asserted-by":"publisher","first-page":"138","DOI":"10.4161\/oxim.2.3.8819","volume":"2","author":"P Gomes","year":"2009","unstructured":"Gomes P et al (2009) Aging increases oxidative stress and renal expression of oxidant and antioxidant enzymes that are associated with an increased trend in systolic blood pressure. Oxidative Med Cell Longev 2(3):138\u2013145","journal-title":"Oxidative Med Cell Longev"},{"issue":"6","key":"23_CR75","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.exger.2011.02.003","volume":"46","author":"S Simao","year":"2011","unstructured":"Simao S et al (2011) Age-related changes in renal expression of oxidant and antioxidant enzymes and oxidative stress markers in male SHR and WKY rats. Exp Gerontol 46(6):468\u2013474","journal-title":"Exp Gerontol"},{"key":"23_CR76","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.freeradbiomed.2012.11.017","volume":"56","author":"P Gomes","year":"2013","unstructured":"Gomes P et al (2013) Loss of oxidative stress tolerance in hypertension is linked to reduced catalase activity and increased c-Jun NH2-terminal kinase activation. Free Radic Biol Med 56:112\u2013122","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"23_CR77","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/S0008-6363(03)00424-3","volume":"59","author":"S Ulker","year":"2003","unstructured":"Ulker S et al (2003) Impaired activities of antioxidant enzymes elicit endothelial dysfunction in spontaneous hypertensive rats despite enhanced vascular nitric oxide generation. Cardiovasc Res 59(2):488\u2013500","journal-title":"Cardiovasc Res"},{"issue":"2","key":"23_CR78","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1161\/HYPERTENSIONAHA.108.116905","volume":"53","author":"SH Chan","year":"2009","unstructured":"Chan SH et al (2009) Oxidative impairment of mitochondrial electron transport chain complexes in rostral ventrolateral medulla contributes to neurogenic hypertension. Hypertension 53(2):217\u2013227","journal-title":"Hypertension"},{"issue":"8 Pt 1","key":"23_CR79","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/S0895-7061(98)00099-5","volume":"11","author":"B Kristal","year":"1998","unstructured":"Kristal B et al (1998) Participation of peripheral polymorphonuclear leukocytes in the oxidative stress and inflammation in patients with essential hypertension. Am J Hypertens 11(8 Pt 1):921\u2013928","journal-title":"Am J Hypertens"},{"issue":"5","key":"23_CR80","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1161\/01.HYP.36.5.878","volume":"36","author":"F Lacy","year":"2000","unstructured":"Lacy F et al (2000) Plasma hydrogen peroxide production in human essential hypertension: role of heredity, gender, and ethnicity. Hypertension 36(5):878\u2013884","journal-title":"Hypertension"},{"issue":"9","key":"23_CR81","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1016\/j.freeradbiomed.2006.07.019","volume":"41","author":"L Zhou","year":"2006","unstructured":"Zhou L et al (2006) Reduction in extracellular superoxide dismutase activity in African-American patients with hypertension. Free Radic Biol Med 41(9):1384\u20131391","journal-title":"Free Radic Biol Med"},{"issue":"5","key":"23_CR82","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1161\/01.HYP.0000068370.21009.38","volume":"41","author":"J Redon","year":"2003","unstructured":"Redon J et\u00a0al (2003) Antioxidant activities and oxidative stress byproducts in human hypertension. Hypertension 41(5):1096\u20131101","journal-title":"Hypertension"},{"issue":"4A","key":"23_CR83","first-page":"635","volume":"9","author":"K Kedziora-Kornatowska","year":"2004","unstructured":"Kedziora-Kornatowska K et al (2004) The markers of oxidative stress and activity of the antioxidant system in the blood of elderly patients with essential arterial hypertension. Cell Mol Biol Lett 9(4A):635\u2013641","journal-title":"Cell Mol Biol Lett"},{"issue":"3","key":"23_CR84","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1007\/BF02940252","volume":"165","author":"Y Wen","year":"1996","unstructured":"Wen Y et al (1996) Lipid peroxidation and antioxidant vitamins C and E in hypertensive patients. Ir J Med Sci 165(3):210\u2013212","journal-title":"Ir J Med Sci"},{"issue":"6","key":"23_CR85","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/sj.jhh.1001034","volume":"14","author":"J Pedro-Botet","year":"2000","unstructured":"Pedro-Botet J et\u00a0al (2000) Decreased endogenous antioxidant enzymatic status in essential hypertension. J Hum Hypertens 14(6):343\u2013345","journal-title":"J Hum Hypertens"},{"issue":"9","key":"23_CR86","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1111\/j.1440-1681.2006.04457.x","volume":"33","author":"NC Ward","year":"2006","unstructured":"Ward NC, Croft KD (2006) Hypertension and oxidative stress. Clin Exp Pharmacol Physiol 33(9):872\u2013876","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"Suppl 2","key":"23_CR87","doi-asserted-by":"publisher","first-page":"S181","DOI":"10.2337\/dc08-s245","volume":"31","author":"A Ceriello","year":"2008","unstructured":"Ceriello A (2008) Possible role of oxidative stress in the pathogenesis of hypertension. Diabetes Care 31(Suppl 2):S181\u2013S184","journal-title":"Diabetes Care"},{"issue":"Suppl 2","key":"23_CR88","doi-asserted-by":"publisher","first-page":"S185","DOI":"10.2337\/dc08-s246","volume":"31","author":"E Grossman","year":"2008","unstructured":"Grossman E (2008) Does increased oxidative stress cause hypertension? Diabetes Care 31(Suppl 2):S185\u2013S189","journal-title":"Diabetes Care"},{"issue":"3","key":"23_CR89","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/S0306-4522(03)00517-7","volume":"121","author":"HH Lin","year":"2003","unstructured":"Lin HH et al (2003) Hydrogen peroxide increases the activity of rat sympathetic preganglionic neurons in vivo and in vitro. Neuroscience 121(3):641\u2013647","journal-title":"Neuroscience"},{"issue":"1","key":"23_CR90","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1161\/01.HYP.36.1.142","volume":"36","author":"ND Vaziri","year":"2000","unstructured":"Vaziri ND et al (2000) Induction of oxidative stress by glutathione depletion causes severe hypertension in normal rats. Hypertension 36(1):142\u2013146","journal-title":"Hypertension"},{"issue":"17","key":"23_CR91","doi-asserted-by":"publisher","first-page":"2668","DOI":"10.1161\/CIRCULATIONAHA.105.538934","volume":"112","author":"A Dikalova","year":"2005","unstructured":"Dikalova A et al (2005) Nox1 overexpression potentiates angiotensin II-induced hypertension and vascular smooth muscle hypertrophy in transgenic mice. Circulation 112(17):2668\u20132676","journal-title":"Circulation"},{"issue":"12","key":"23_CR92","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1038\/ki.2010.63","volume":"77","author":"N Godin","year":"2010","unstructured":"Godin N et al (2010) Catalase overexpression prevents hypertension and tubular apoptosis in angiotensinogen transgenic mice. Kidney Int 77(12):1086\u20131097","journal-title":"Kidney Int"},{"issue":"2","key":"23_CR93","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.febslet.2005.12.049","volume":"580","author":"G Gavazzi","year":"2006","unstructured":"Gavazzi G et al (2006) Decreased blood pressure in NOX1-deficient mice. FEBS Lett 580(2):497\u2013504","journal-title":"FEBS Lett"},{"issue":"12","key":"23_CR94","doi-asserted-by":"publisher","first-page":"3660","DOI":"10.1002\/jcb.23299","volume":"112","author":"S Simao","year":"2011","unstructured":"Simao S et al (2011) H2 O2 stimulates Cl- \/HCO 3- exchanger activity through oxidation of thiol groups in immortalized SHR renal proximal tubular epithelial cells. J Cell Biochem 112(12):3660\u20133665","journal-title":"J Cell Biochem"},{"issue":"5","key":"23_CR95","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1080\/10641960701500398","volume":"29","author":"AT Baumer","year":"2007","unstructured":"Baumer AT et al (2007) The NAD(P)H oxidase inhibitor apocynin improves endothelial NO\/superoxide balance and lowers effectively blood pressure in spontaneously hypertensive rats: comparison to calcium channel blockade. Clin Exp Hypertens 29(5):287\u2013299","journal-title":"Clin Exp Hypertens"},{"issue":"5","key":"23_CR96","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1161\/hy1101.093423","volume":"38","author":"RA Beswick","year":"2001","unstructured":"Beswick RA et al (2001) NADH\/NADPH oxidase and enhanced superoxide production in the mineralocorticoid hypertensive rat. Hypertension 38(5):1107\u20131111","journal-title":"Hypertension"},{"issue":"2\u20133","key":"23_CR97","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.ejphar.2008.04.044","volume":"588","author":"T Sousa","year":"2008","unstructured":"Sousa T et al (2008) Role of superoxide and hydrogen peroxide in hypertension induced by an antagonist of adenosine receptors. Eur J Pharmacol 588(2\u20133):267\u2013276","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"23_CR98","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.amjhyper.2003.11.004","volume":"17","author":"Y Zhang","year":"2004","unstructured":"Zhang Y et al (2004) The antioxidant tempol prevents and partially reverses dexamethasone-induced hypertension in the rat. Am J Hypertens 17(3):260\u2013265","journal-title":"Am J Hypertens"},{"issue":"1","key":"23_CR99","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1081\/CEH-200044267","volume":"27","author":"L Nabha","year":"2005","unstructured":"Nabha L et al (2005) Vascular oxidative stress precedes high blood pressure in spontaneously hypertensive rats. Clin Exp Hypertens 27(1):71\u201382","journal-title":"Clin Exp Hypertens"},{"issue":"4","key":"23_CR100","first-page":"R913","volume":"289","author":"CS Wilcox","year":"2005","unstructured":"Wilcox CS (2005) Oxidative stress and nitric oxide deficiency in the kidney: a critical link to hypertension? Am J Phys Regul Integr Comp Phys 289(4):R913\u2013R935","journal-title":"Am J Phys Regul Integr Comp Phys"},{"issue":"9326","key":"23_CR101","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0140-6736(02)09328-5","volume":"360","author":"Heart Protection Study Collaborative, G","year":"2002","unstructured":"Heart Protection Study Collaborative, G (2002) MRC\/BHF heart protection study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360(9326):23\u201333","journal-title":"Lancet"},{"issue":"17","key":"23_CR102","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1001\/jama.2012.14805","volume":"308","author":"HD Sesso","year":"2012","unstructured":"Sesso HD et al (2012) Multivitamins in the prevention of cardiovascular disease in men: the physicians\u2019 health study II randomized controlled trial. JAMA 308(17):1751\u20131760","journal-title":"JAMA"},{"issue":"9374","key":"23_CR103","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1016\/S0140-6736(03)13637-9","volume":"361","author":"DP Vivekananthan","year":"2003","unstructured":"Vivekananthan DP et al (2003) Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials. Lancet 361(9374):2017\u20132023","journal-title":"Lancet"},{"issue":"6","key":"23_CR104","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1097\/00004872-200306000-00022","volume":"21","author":"Y Baykal","year":"2003","unstructured":"Baykal Y et al (2003) Effects of antihypertensive agents, alpha receptor blockers, beta blockers, angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and calcium channel blockers, on oxidative stress. J Hypertens 21(6):1207\u20131211","journal-title":"J Hypertens"},{"issue":"12","key":"23_CR105","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1038\/ajh.2010.167","volume":"23","author":"EM Cavanagh de","year":"2010","unstructured":"de Cavanagh EM et al (2010) Vascular structure and oxidative stress in salt-loaded spontaneously hypertensive rats: effects of losartan and atenolol. Am J Hypertens 23(12):1318\u20131325","journal-title":"Am J Hypertens"},{"issue":"10","key":"23_CR106","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.1093\/jn\/136.10.2588","volume":"136","author":"L Dauchet","year":"2006","unstructured":"Dauchet L et al (2006) Fruit and vegetable consumption and risk of coronary heart disease: a meta-analysis of cohort studies. J Nutr 136(10):2588\u20132593","journal-title":"J Nutr"},{"issue":"10A","key":"23_CR107","doi-asserted-by":"publisher","first-page":"14D","DOI":"10.1016\/j.amjcard.2008.02.003","volume":"101","author":"SR Steinhubl","year":"2008","unstructured":"Steinhubl SR (2008) Why have antioxidants failed in clinical trials? Am J Cardiol 101(10A):14D\u201319D","journal-title":"Am J Cardiol"},{"issue":"4","key":"23_CR108","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/nrcardio.2016.203","volume":"14","author":"DA Brown","year":"2017","unstructured":"Brown DA et al (2017) Expert consensus document: mitochondrial function as a therapeutic target in heart failure. Nat Rev Cardiol 14(4):238\u2013250","journal-title":"Nat Rev Cardiol"},{"issue":"3","key":"23_CR109","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1172\/JCI200524408","volume":"115","author":"FJ Giordano","year":"2005","unstructured":"Giordano FJ (2005) Oxygen, oxidative stress, hypoxia, and heart failure. J Clin Invest 115(3):500\u2013508","journal-title":"J Clin Invest"},{"key":"23_CR110","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.redox.2014.05.006","volume":"2","author":"T Kalogeris","year":"2014","unstructured":"Kalogeris T, Bao Y, Korthuis RJ (2014) Mitochondrial reactive oxygen species: a double edged sword in ischemia\/reperfusion vs preconditioning. Redox Biol 2:702\u2013714","journal-title":"Redox Biol"},{"issue":"1","key":"23_CR111","doi-asserted-by":"publisher","first-page":"H165","DOI":"10.1152\/ajpheart.00906.2009","volume":"299","author":"RA Haworth","year":"2010","unstructured":"Haworth RA, Potter KT, Russell DC (2010) Role of arachidonic acid, lipoxygenase, and mitochondrial depolarization in reperfusion arrhythmias. Am J Physiol Heart Circ Physiol 299(1):H165\u2013H174","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"7","key":"23_CR112","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.freeradbiomed.2011.01.003","volume":"50","author":"CX Santos","year":"2011","unstructured":"Santos CX et al (2011) Redox signaling in cardiac myocytes. Free Radic Biol Med 50(7):777\u2013793","journal-title":"Free Radic Biol Med"},{"issue":"Pt 5","key":"23_CR113","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1242\/jcs.03386","volume":"120","author":"M Buggisch","year":"2007","unstructured":"Buggisch M et al (2007) Stimulation of ES-cell-derived cardiomyogenesis and neonatal cardiac cell proliferation by reactive oxygen species and NADPH oxidase. J Cell Sci 120(Pt 5):885\u2013894","journal-title":"J Cell Sci"},{"issue":"3","key":"23_CR114","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/S0014-5793(00)01747-6","volume":"476","author":"H Sauer","year":"2000","unstructured":"Sauer H et al (2000) Role of reactive oxygen species and phosphatidylinositol 3-kinase in cardiomyocyte differentiation of embryonic stem cells. FEBS Lett 476(3):218\u2013223","journal-title":"FEBS Lett"},{"issue":"6","key":"23_CR115","doi-asserted-by":"publisher","first-page":"H3720","DOI":"10.1152\/ajpheart.00436.2007","volume":"293","author":"S Saitoh","year":"2007","unstructured":"Saitoh S et al (2007) Redox-dependent coronary metabolic dilation. Am J Physiol Heart Circ Physiol 293(6):H3720\u2013H3725","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"12","key":"23_CR116","doi-asserted-by":"publisher","first-page":"2614","DOI":"10.1161\/01.ATV.0000249408.55796.da","volume":"26","author":"S Saitoh","year":"2006","unstructured":"Saitoh S et al (2006) Hydrogen peroxide: a feed-forward dilator that couples myocardial metabolism to coronary blood flow. Arterioscler Thromb Vasc Biol 26(12):2614\u20132621","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"Pt 7","key":"23_CR117","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1113\/jphysiol.2010.202838","volume":"589","author":"DC Andersson","year":"2011","unstructured":"Andersson DC et al (2011) Mitochondrial production of reactive oxygen species contributes to the beta-adrenergic stimulation of mouse cardiomycytes. J Physiol 589(Pt 7):1791\u20131801","journal-title":"J Physiol"},{"issue":"4","key":"23_CR118","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/cdd.2008.13","volume":"15","author":"G Loor","year":"2008","unstructured":"Loor G, Schumacker PT (2008) Role of hypoxia-inducible factor in cell survival during myocardial ischemia-reperfusion. Cell Death Differ 15(4):686\u2013690","journal-title":"Cell Death Differ"},{"issue":"42","key":"23_CR119","doi-asserted-by":"publisher","first-page":"18121","DOI":"10.1073\/pnas.1009700107","volume":"107","author":"M Zhang","year":"2010","unstructured":"Zhang M et al (2010) NADPH oxidase-4 mediates protection against chronic load-induced stress in mouse hearts by enhancing angiogenesis. Proc Natl Acad Sci U S A 107(42):18121\u201318126","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"23_CR120","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1002\/ejhf.592","volume":"18","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P et al (2016) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 18(8):891\u2013975","journal-title":"Eur J Heart Fail"},{"issue":"10","key":"23_CR121","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.2174\/1389450117666160101121135","volume":"17","author":"M Reina-Couto","year":"2016","unstructured":"Reina-Couto M et al (2016) Resolving inflammation in heart failure: novel protective lipid mediators. Curr Drug Targets 17(10):1206\u20131223","journal-title":"Curr Drug Targets"},{"issue":"9970","key":"23_CR122","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/S0140-6736(14)61889-4","volume":"385","author":"E Braunwald","year":"2015","unstructured":"Braunwald E (2015) The war against heart failure: the lancet lecture. Lancet 385(9970):812\u2013824","journal-title":"Lancet"},{"issue":"2","key":"23_CR123","doi-asserted-by":"publisher","first-page":"123","DOI":"10.2174\/1573403X11309020005","volume":"9","author":"K Guha","year":"2013","unstructured":"Guha K, McDonagh T (2013) Heart failure epidemiology: European perspective. Curr Cardiol Rev 9(2):123\u2013127","journal-title":"Curr Cardiol Rev"},{"issue":"2","key":"23_CR124","doi-asserted-by":"publisher","first-page":"180","DOI":"10.4065\/mcp.2009.0494","volume":"85","author":"GV Ramani","year":"2010","unstructured":"Ramani GV, Uber PA, Mehra MR (2010) Chronic heart failure: contemporary diagnosis and management. Mayo Clin Proc 85(2):180\u2013195","journal-title":"Mayo Clin Proc"},{"issue":"7","key":"23_CR125","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1056\/NEJMra022643","volume":"349","author":"DH Spodick","year":"2003","unstructured":"Spodick DH (2003) Acute cardiac tamponade. N Engl J Med 349(7):684\u2013690","journal-title":"N Engl J Med"},{"issue":"4","key":"23_CR126","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/clpt.2010.116","volume":"88","author":"S Haehling von","year":"2010","unstructured":"von Haehling S et al (2010) Elevated levels of asymmetric dimethylarginine in chronic heart failure: a pathophysiologic link between oxygen radical load and impaired vasodilator capacity and the therapeutic effect of allopurinol. Clin Pharmacol Ther 88(4):506\u2013512","journal-title":"Clin Pharmacol Ther"},{"issue":"11 Pt A","key":"23_CR127","doi-asserted-by":"publisher","first-page":"2822","DOI":"10.1016\/j.bbagen.2017.07.027","volume":"1861","author":"GN Kanaan","year":"2017","unstructured":"Kanaan GN, Harper ME (2017) Cellular redox dysfunction in the development of cardiovascular diseases. Biochim Biophys Acta Gen Subj 1861(11 Pt A):2822\u20132829","journal-title":"Biochim Biophys Acta Gen Subj"},{"issue":"2","key":"23_CR128","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/eurjhf\/hfn043","volume":"11","author":"S Heymans","year":"2009","unstructured":"Heymans S et al (2009) Inflammation as a therapeutic target in heart failure? A scientific statement from the translational research Committee of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 11(2):119\u2013129","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"23_CR129","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1007\/s00395-013-0356-y","volume":"108","author":"U Hofmann","year":"2013","unstructured":"Hofmann U, Frantz S (2013) How can we cure a heart \u201cin flame\u201d? A translational view on inflammation in heart failure. Basic Res Cardiol 108(4):356","journal-title":"Basic Res Cardiol"},{"issue":"4","key":"23_CR130","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.ahj.2005.06.046","volume":"151","author":"C Mueller","year":"2006","unstructured":"Mueller C et al (2006) Inflammation and long-term mortality in acute congestive heart failure. Am Heart J 151(4):845\u2013850","journal-title":"Am Heart J"},{"issue":"7","key":"23_CR131","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1089\/ars.2009.2930","volume":"13","author":"N Khaper","year":"2010","unstructured":"Khaper N et al (2010) Targeting the vicious inflammation-oxidative stress cycle for the management of heart failure. Antioxid Redox Signal 13(7):1033\u20131049","journal-title":"Antioxid Redox Signal"},{"issue":"4","key":"23_CR132","doi-asserted-by":"publisher","first-page":"245","DOI":"10.2174\/157340208786241336","volume":"4","author":"X Chen","year":"2008","unstructured":"Chen X et al (2008) Role of reactive oxygen species in tumor necrosis factor-alpha induced endothelial dysfunction. Curr Hypertens Rev 4(4):245\u2013255","journal-title":"Curr Hypertens Rev"},{"issue":"6","key":"23_CR133","doi-asserted-by":"publisher","first-page":"H2563","DOI":"10.1152\/ajpheart.00435.2003","volume":"285","author":"C Zhang","year":"2003","unstructured":"Zhang C et al (2003) Interaction of myeloperoxidase with vascular NAD(P)H oxidase-derived reactive oxygen species in vasculature: implications for vascular diseases. Am J Physiol Heart Circ Physiol 285(6):H2563\u2013H2572","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"6","key":"23_CR134","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1111\/eci.12265","volume":"44","author":"M Reina-Couto","year":"2014","unstructured":"Reina-Couto M et al (2014) Impaired resolution of inflammation in human chronic heart failure. Eur J Clin Investig 44(6):527\u2013538","journal-title":"Eur J Clin Investig"},{"key":"23_CR135","first-page":"P459","volume":"20","author":"M Reina-Couto","year":"2018","unstructured":"Reina-Couto M et al (2018) Endocan as a new biomarker of severity in acute heart failure. Eur J Heart Fail 20:P459","journal-title":"Eur J Heart Fail"},{"issue":"e-Supplement 1","key":"23_CR136","doi-asserted-by":"publisher","first-page":"e211","DOI":"10.1097\/01.hjh.0000539595.60360.5f","volume":"36","author":"M Reina-Couto","year":"2018","unstructured":"Reina-Couto M et al (2018) Inflammation resolution mediators in acute heart failure. J Hypertens 36(e-Supplement 1):e211","journal-title":"J Hypertens"},{"issue":"38","key":"23_CR137","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.1093\/eurheartj\/ehv305","volume":"36","author":"T Munzel","year":"2015","unstructured":"Munzel T et al (2015) Pathophysiological role of oxidative stress in systolic and diastolic heart failure and its therapeutic implications. Eur Heart J 36(38):2555\u20132564","journal-title":"Eur Heart J"},{"issue":"7","key":"23_CR138","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1002\/ejhf.110","volume":"16","author":"EE Riet van","year":"2014","unstructured":"van Riet EE et al (2014) Prevalence of unrecognized heart failure in older persons with shortness of breath on exertion. Eur J Heart Fail 16(7):772\u2013777","journal-title":"Eur J Heart Fail"},{"issue":"25","key":"23_CR139","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1093\/eurheartj\/ehv126","volume":"36","author":"K Karimi Galougahi","year":"2015","unstructured":"Karimi Galougahi K et al (2015) Redox biomarkers in cardiovascular medicine. Eur Heart J 36(25):1576\u20131582. 1582a-b","journal-title":"Eur Heart J"},{"issue":"4","key":"23_CR140","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1161\/CIRCULATIONAHA.115.019790","volume":"133","author":"RS Patel","year":"2016","unstructured":"Patel RS et al (2016) Novel biomarker of oxidative stress is associated with risk of death in patients with coronary artery disease. Circulation 133(4):361\u2013369","journal-title":"Circulation"},{"issue":"20","key":"23_CR141","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1056\/NEJMra0800239","volume":"358","author":"E Braunwald","year":"2008","unstructured":"Braunwald E (2008) Biomarkers in heart failure. N Engl J Med 358(20):2148\u20132159","journal-title":"N Engl J Med"},{"issue":"6","key":"23_CR142","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.amjcard.2006.04.018","volume":"98","author":"WH Tang","year":"2006","unstructured":"Tang WH et al (2006) Plasma myeloperoxidase levels in patients with chronic heart failure. Am J Cardiol 98(6):796\u2013799","journal-title":"Am J Cardiol"},{"key":"23_CR143","doi-asserted-by":"publisher","first-page":"9704","DOI":"10.1038\/srep09704","volume":"5","author":"M Adam","year":"2015","unstructured":"Adam M et al (2015) Levosimendan displays anti-inflammatory effects and decreases MPO bioavailability in patients with severe heart failure. Sci Rep 5:9704","journal-title":"Sci Rep"},{"issue":"5","key":"23_CR144","doi-asserted-by":"crossref","first-page":"e002586","DOI":"10.1161\/JAHA.115.002586","volume":"5","author":"ML O\u2019Donoghue","year":"2016","unstructured":"O\u2019Donoghue ML et al (2016) Multimarker risk stratification in patients with acute myocardial infarction. J Am Heart Assoc 5(5):e002586","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"23_CR145","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1159\/000492602","volume":"8","author":"GM Virzi","year":"2018","unstructured":"Virzi GM et al (2018) Levels of proinflammatory cytokines, oxidative stress, and tissue damage markers in patients with acute heart failure with and without cardiorenal syndrome type 1. Cardiorenal Med 8(4):321\u2013331","journal-title":"Cardiorenal Med"},{"issue":"2","key":"23_CR146","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.atherosclerosis.2013.11.075","volume":"232","author":"Y Kataoka","year":"2014","unstructured":"Kataoka Y et al (2014) Myeloperoxidase levels predict accelerated progression of coronary atherosclerosis in diabetic patients: insights from intravascular ultrasound. Atherosclerosis 232(2):377\u2013383","journal-title":"Atherosclerosis"},{"issue":"2","key":"23_CR147","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.jacc.2007.03.033","volume":"50","author":"MC Meuwese","year":"2007","unstructured":"Meuwese MC et al (2007) Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals: the EPIC-norfolk prospective population study. J Am Coll Cardiol 50(2):159\u2013165","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"23_CR148","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1089\/ars.2015.6326","volume":"23","author":"D Pastori","year":"2015","unstructured":"Pastori D et al (2015) Does mediterranean diet reduce cardiovascular events and oxidative stress in atrial fibrillation? Antioxid Redox Signal 23(8):682\u2013687","journal-title":"Antioxid Redox Signal"},{"issue":"11","key":"23_CR149","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1161\/CIRCULATIONAHA.111.038919","volume":"125","author":"C Cunnington","year":"2012","unstructured":"Cunnington C et al (2012) Systemic and vascular oxidation limits the efficacy of oral tetrahydrobiopterin treatment in patients with coronary artery disease. Circulation 125(11):1356\u20131366","journal-title":"Circulation"},{"issue":"17","key":"23_CR150","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1161\/CIRCULATIONAHA.106.679084","volume":"115","author":"C Shirodaria","year":"2007","unstructured":"Shirodaria C et al (2007) Global improvement of vascular function and redox state with low-dose folic acid: implications for folate therapy in patients with coronary artery disease. Circulation 115(17):2262\u20132270","journal-title":"Circulation"},{"issue":"19","key":"23_CR151","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.2174\/1381612824666180608102344","volume":"24","author":"CN Santos","year":"2018","unstructured":"Santos CN et al (2018) Pure polyphenols applications for cardiac health and disease. Curr Pharm Des 24(19):2137\u20132156","journal-title":"Curr Pharm Des"},{"issue":"2","key":"23_CR152","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/FJC.0000000000000599","volume":"72","author":"C Driver","year":"2018","unstructured":"Driver C et al (2018) Cardioprotective effects of metformin. J Cardiovasc Pharmacol 72(2):121\u2013127","journal-title":"J Cardiovasc Pharmacol"},{"issue":"17","key":"23_CR153","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1016\/j.jacc.2017.02.048","volume":"69","author":"M Alemayehu","year":"2017","unstructured":"Alemayehu M et al (2017) Effect of ticagrelor versus clopidogrel on vascular reactivity. J Am Coll Cardiol 69(17):2246\u20132248","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"23_CR154","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1161\/ATVBAHA.114.304002","volume":"34","author":"MK Nanhwan","year":"2014","unstructured":"Nanhwan MK et al (2014) Chronic treatment with ticagrelor limits myocardial infarct size: an adenosine and cyclooxygenase-2-dependent effect. Arterioscler Thromb Vasc Biol 34(9):2078\u20132085","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"15","key":"23_CR155","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1096\/fj.04-2330rev","volume":"18","author":"P Montuschi","year":"2004","unstructured":"Montuschi P, Barnes PJ, Roberts LJ 2nd (2004) Isoprostanes: markers and mediators of oxidative stress. FASEB J 18(15):1791\u20131800","journal-title":"FASEB J"},{"issue":"16","key":"23_CR156","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1161\/01.CIR.97.16.1536","volume":"97","author":"Z Mallat","year":"1998","unstructured":"Mallat Z et al (1998) Elevated levels of 8-iso-prostaglandin F2alpha in pericardial fluid of patients with heart failure: a potential role for in vivo oxidant stress in ventricular dilatation and progression to heart failure. Circulation 97(16):1536\u20131539","journal-title":"Circulation"},{"issue":"4","key":"23_CR157","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.cardfail.2003.11.004","volume":"10","author":"MC Polidori","year":"2004","unstructured":"Polidori MC et al (2004) Increased F2 isoprostane plasma levels in patients with congestive heart failure are correlated with antioxidant status and disease severity. J Card Fail 10(4):334\u2013338","journal-title":"J Card Fail"},{"issue":"5","key":"23_CR158","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.freeradbiomed.2010.11.023","volume":"50","author":"SS Davies","year":"2011","unstructured":"Davies SS, Roberts LJ 2nd (2011) F2-isoprostanes as an indicator and risk factor for coronary heart disease. Free Radic Biol Med 50(5):559\u2013566","journal-title":"Free Radic Biol Med"},{"issue":"5","key":"23_CR159","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1161\/HYPERTENSIONAHA.112.202705","volume":"60","author":"SL Hummel","year":"2012","unstructured":"Hummel SL et al (2012) Low-sodium dietary approaches to stop hypertension diet reduces blood pressure, arterial stiffness, and oxidative stress in hypertensive heart failure with preserved ejection fraction. Hypertension 60(5):1200\u20131206","journal-title":"Hypertension"},{"issue":"10","key":"23_CR160","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1111\/j.1440-1681.2011.05580.x","volume":"38","author":"LR Meirelles de","year":"2011","unstructured":"de Meirelles LR et al (2011) Platelet activation, oxidative stress and overexpression of inducible nitric oxide synthase in moderate heart failure. Clin Exp Pharmacol Physiol 38(10):705\u2013710","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"2","key":"23_CR161","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S1388-9842(02)00002-8","volume":"4","author":"GR Ellis","year":"2002","unstructured":"Ellis GR et al (2002) Addition of candesartan to angiotensin converting enzyme inhibitor therapy in patients with chronic heart failure does not reduce levels of oxidative stress. Eur J Heart Fail 4(2):193\u2013199","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"23_CR162","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1042\/CS20050317","volume":"110","author":"M White","year":"2006","unstructured":"White M et al (2006) Increased systemic inflammation and oxidative stress in patients with worsening congestive heart failure: improvement after short-term inotropic support. Clin Sci (Lond) 110(4):483\u2013489","journal-title":"Clin Sci (Lond)"},{"issue":"10","key":"23_CR163","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1136\/hrt.2003.018226","volume":"90","author":"T Amaki","year":"2004","unstructured":"Amaki T et al (2004) Circulating malondialdehyde modified LDL is a biochemical risk marker for coronary artery disease. Heart 90(10):1211\u20131213","journal-title":"Heart"},{"issue":"9","key":"23_CR164","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/j.amjcard.2015.07.053","volume":"116","author":"G Charach","year":"2015","unstructured":"Charach G et al (2015) Usefulness of antibodies to oxidized low-density lipoproteins as predictors of morbidity and prognosis in heart failure patients aged >\/=65 years. Am J Cardiol 116(9):1379\u20131384","journal-title":"Am J Cardiol"},{"issue":"2","key":"23_CR165","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1097\/HCR.0000000000000229","volume":"37","author":"M Kato","year":"2017","unstructured":"Kato M et al (2017) Stretching exercises improve vascular endothelial dysfunction through attenuation of oxidative stress in chronic heart failure patients with an implantable cardioverter defibrillator. J Cardiopulm Rehabil Prev 37(2):130\u2013138","journal-title":"J Cardiopulm Rehabil Prev"},{"issue":"5","key":"23_CR166","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1111\/aor.12580","volume":"40","author":"NK Mondal","year":"2016","unstructured":"Mondal NK et al (2016) Systemic inflammatory response syndrome in end-stage heart failure patients following continuous-flow left ventricular assist device implantation: differences in plasma redox status and leukocyte activation. Artif Organs 40(5):434\u2013443","journal-title":"Artif Organs"},{"issue":"8","key":"23_CR167","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1161\/01.CIR.0000156461.81529.D7","volume":"111","author":"AJ Lokuta","year":"2005","unstructured":"Lokuta AJ et al (2005) Increased nitration of sarcoplasmic reticulum Ca2+-ATPase in human heart failure. Circulation 111(8):988\u2013995","journal-title":"Circulation"},{"issue":"11","key":"23_CR168","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1161\/CIRCRESAHA.114.302849","volume":"114","author":"A Cabassi","year":"2014","unstructured":"Cabassi A et al (2014) Low serum ferroxidase I activity is associated with mortality in heart failure and related to both peroxynitrite-induced cysteine oxidation and tyrosine nitration of ceruloplasmin. Circ Res 114(11):1723\u20131732","journal-title":"Circ Res"},{"issue":"2","key":"23_CR169","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.cardiores.2007.04.024","volume":"75","author":"G Peluffo","year":"2007","unstructured":"Peluffo G, Radi R (2007) Biochemistry of protein tyrosine nitration in cardiovascular pathology. Cardiovasc Res 75(2):291\u2013302","journal-title":"Cardiovasc Res"},{"key":"23_CR170","first-page":"686","volume":"7","author":"B Ahn","year":"2016","unstructured":"Ahn B et al (2016) Diaphragm abnormalities in patients with end-stage heart failure: NADPH oxidase upregulation and protein oxidation. Front Physiol 7:686","journal-title":"Front Physiol"},{"issue":"2","key":"23_CR171","doi-asserted-by":"publisher","first-page":"e210","DOI":"10.1016\/j.atherosclerosis.2007.07.011","volume":"195","author":"JT Parissis","year":"2007","unstructured":"Parissis JT et al (2007) Effects of Levosimendan on circulating markers of oxidative and nitrosative stress in patients with advanced heart failure. Atherosclerosis 195(2):e210\u2013e215","journal-title":"Atherosclerosis"},{"issue":"6","key":"23_CR172","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1161\/01.HYP.0000222893.85662.cd","volume":"47","author":"VA Cameron","year":"2006","unstructured":"Cameron VA et al (2006) Angiotensin type-1 receptor A1166C gene polymorphism correlates with oxidative stress levels in human heart failure. Hypertension 47(6):1155\u20131161","journal-title":"Hypertension"},{"issue":"1","key":"23_CR173","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1093\/eurjhf\/hfq178","volume":"13","author":"S Kobayashi","year":"2011","unstructured":"Kobayashi S et al (2011) Urinary 8-hydroxy-2\u2032-deoxyguanosine reflects symptomatic status and severity of systolic dysfunction in patients with chronic heart failure. Eur J Heart Fail 13(1):29\u201336","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"23_CR174","doi-asserted-by":"publisher","first-page":"308","DOI":"10.3109\/10641963.2012.721842","volume":"35","author":"H Masugata","year":"2013","unstructured":"Masugata H et al (2013) Association between oxidative stress assessed by urinary 8-hydroxydeoxyguanosine and the cardiac function in hypertensive patients without overt heart disease. Clin Exp Hypertens 35(5):308\u2013312","journal-title":"Clin Exp Hypertens"},{"issue":"1","key":"23_CR175","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1253\/circj.CJ-11-0537","volume":"76","author":"T Susa","year":"2012","unstructured":"Susa T et al (2012) Urinary 8-hydroxy-2\u2032-deoxyguanosine as a novel biomarker for predicting cardiac events and evaluating the effectiveness of carvedilol treatment in patients with chronic systolic heart failure. Circ J 76(1):117\u2013126","journal-title":"Circ J"},{"issue":"17","key":"23_CR176","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1056\/NEJMoa030535","volume":"349","author":"S Blankenberg","year":"2003","unstructured":"Blankenberg S et al (2003) Glutathione peroxidase 1 activity and cardiovascular events in patients with coronary artery disease. N Engl J Med 349(17):1605\u20131613","journal-title":"N Engl J Med"},{"issue":"11","key":"23_CR177","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.healun.2007.07.009","volume":"26","author":"R Caruso","year":"2007","unstructured":"Caruso R et al (2007) Pre-operative redox state affects 1-month survival in patients with advanced heart failure undergoing left ventricular assist device implantation. J Heart Lung Transplant 26(11):1177\u20131181","journal-title":"J Heart Lung Transplant"},{"issue":"6","key":"23_CR178","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.cardfail.2005.01.007","volume":"11","author":"F Sam","year":"2005","unstructured":"Sam F et al (2005) Increased reactive oxygen species production and functional alterations in antioxidant enzymes in human failing myocardium. J Card Fail 11(6):473\u2013480","journal-title":"J Card Fail"},{"issue":"10","key":"23_CR179","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1016\/j.jacc.2004.01.028","volume":"43","author":"J Hokamaki","year":"2004","unstructured":"Hokamaki J et\u00a0al (2004) Urinary biopyrrins levels are elevated in relation to severity of heart failure. J Am Coll Cardiol 43(10):1880\u20131885","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"23_CR180","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1179\/1351000213Y.0000000083","volume":"19","author":"HY Ellidag","year":"2014","unstructured":"Ellidag HY et al (2014) Oxidative stress and ischemia-modified albumin in chronic ischemic heart failure. Redox Rep 19(3):118\u2013123","journal-title":"Redox Rep"},{"issue":"11","key":"23_CR181","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1001\/jama.293.11.1338","volume":"293","author":"E Lonn","year":"2005","unstructured":"Lonn E et al (2005) Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA 293(11):1338\u20131347","journal-title":"JAMA"},{"issue":"5","key":"23_CR182","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1093\/qjmed\/hcn160","volume":"102","author":"MJ Thomson","year":"2009","unstructured":"Thomson MJ, Frenneaux MP, Kaski JC (2009) Antioxidant treatment for heart failure: friend or foe? QJM 102(5):305\u2013310","journal-title":"QJM"},{"issue":"4","key":"23_CR183","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1536\/ihj.16-359","volume":"58","author":"Y Yamauchi","year":"2017","unstructured":"Yamauchi Y et al (2017) Is serum uric acid independently associated with left ventricular mass index, ejection fraction, and B-type natriuretic peptide among female and male cardiac patients? Int Heart J 58(4):562\u2013569","journal-title":"Int Heart J"},{"key":"23_CR184","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.ijcard.2017.11.083","volume":"252","author":"SG Wannamethee","year":"2018","unstructured":"Wannamethee SG et al (2018) Serum uric acid as a potential marker for heart failure risk in men on antihypertensive treatment: the British regional heart study. Int J Cardiol 252:187\u2013192","journal-title":"Int J Cardiol"}],"container-title":["Oxidative Stress in Heart Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-981-13-8273-4_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T20:34:41Z","timestamp":1664829281000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-981-13-8273-4_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9789811382727","9789811382734"],"references-count":184,"URL":"https:\/\/doi.org\/10.1007\/978-981-13-8273-4_23","relation":{},"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"7 November 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}